Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 19, 2023 09:00 ET | Source: Heart Test Laboratories, Inc.

HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results

Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
May 17, 2023 08:00 ET | Source: Heart Test Laboratories, Inc.

HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine

Southlake, Texas, May 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
May 09, 2023 08:15 ET | Source: Heart Test Laboratories, Inc.

HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG

Southlake, Texas, May 09, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
May 08, 2023 08:15 ET | Source: Heart Test Laboratories, Inc.

HeartSciences to Participate at the Inaugural EF Hutton Global Conference

Southlake, Texas, May 08, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
May 02, 2023 08:15 ET | Source: Heart Test Laboratories, Inc.

HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference

Southlake, Texas, May 02, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a next-generation, AI ECG medical...
April 17, 2023 08:15 ET | Source: Heart Test Laboratories, Inc.

HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023

Southlake, Texas, April 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...
March 16, 2023 16:15 ET | Source: Heart Test Laboratories, Inc.

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results

Southlake, Texas, March 16, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...
February 07, 2023 11:04 ET | Source: Heart Test Laboratories, Inc.

HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time

Southlake, Texas, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...
February 06, 2023 07:30 ET | Source: Heart Test Laboratories, Inc.

HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease

Southlake, Texas, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...
February 03, 2023 09:00 ET | Source: Heart Test Laboratories, Inc.

HeartSciences Announces Further Internationalization of its Patent Portfolio

Southlake, Texas, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...